Value of neutrophil lymphocyte ratio in patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib
Crossref DOI link: https://doi.org/10.1007/s12032-014-0068-7
Published Online: 2014-06-14
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Agilli, Mehmet
Aydin, Fevzi Nuri
Kurt, Yasemin Gulcan
Text and Data Mining valid from 2014-06-14